Ibere Pharmaceuticals

General Information

Ibere Pharmaceuticals is a blank check company that intends to target pharmaceutical companies or life sciences companies with strong international brands. PIPV Capital, a private equity firm focused on healthcare, created this SPAC, which is incorporated in the Cayman Islands.)

Osagie Imasogie, our chairman and CEO, is a co-founder and senior managing partner of PIPV Capital. He was previously the founding vice president of GlaxosmithKline Ventures.

Lisa Gray, our CFO, and Zoltan Kerekes, our COO, are co-founders and managing partners of PIPV Capital.

(Note: Ibere Pharmaceuticals upsized its SPAC IPO at pricing on Feb. 25, 2021: 12 million units, up from 10  million, were priced at $10 each to raise $120 million.)

Employees: 0
Founded: 2021
Contact Information
Address 2005 Market Street, Suite 2030 Philadelphia, PA 19103, US
Phone Number (267) 765-3222
Web Address
View Prospectus: Ibere Pharmaceuticals
Financial Information
Market Cap $145mil
Revenues $0 mil (last 12 months)
Net Income $0 mil (last 12 months)
IPO Profile
Symbol IBERU
Exchange NYSE
Shares (millions): 12.0
Price range $10.00 - $10.00
Est. $ Volume $120.0 mil
Manager / Joint Managers Raymond James
CO-Managers -
Expected To Trade: 2/26/2021
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change